1. Home
  2. ANVS vs GNSS Comparison

ANVS vs GNSS Comparison

Compare ANVS & GNSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • GNSS
  • Stock Information
  • Founded
  • ANVS 2008
  • GNSS 1992
  • Country
  • ANVS United States
  • GNSS United States
  • Employees
  • ANVS N/A
  • GNSS N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • GNSS Consumer Electronics/Appliances
  • Sector
  • ANVS Health Care
  • GNSS Consumer Staples
  • Exchange
  • ANVS Nasdaq
  • GNSS Nasdaq
  • Market Cap
  • ANVS 44.6M
  • GNSS 78.1M
  • IPO Year
  • ANVS 2020
  • GNSS N/A
  • Fundamental
  • Price
  • ANVS $2.75
  • GNSS $1.96
  • Analyst Decision
  • ANVS Strong Buy
  • GNSS Strong Buy
  • Analyst Count
  • ANVS 4
  • GNSS 3
  • Target Price
  • ANVS $18.00
  • GNSS $5.33
  • AVG Volume (30 Days)
  • ANVS 437.3K
  • GNSS 131.5K
  • Earning Date
  • ANVS 08-14-2025
  • GNSS 08-05-2025
  • Dividend Yield
  • ANVS N/A
  • GNSS N/A
  • EPS Growth
  • ANVS N/A
  • GNSS N/A
  • EPS
  • ANVS N/A
  • GNSS N/A
  • Revenue
  • ANVS N/A
  • GNSS $27,780,000.00
  • Revenue This Year
  • ANVS N/A
  • GNSS $91.14
  • Revenue Next Year
  • ANVS N/A
  • GNSS $75.44
  • P/E Ratio
  • ANVS N/A
  • GNSS N/A
  • Revenue Growth
  • ANVS N/A
  • GNSS N/A
  • 52 Week Low
  • ANVS $1.11
  • GNSS $1.46
  • 52 Week High
  • ANVS $14.80
  • GNSS $4.04
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 57.81
  • GNSS 70.78
  • Support Level
  • ANVS $2.24
  • GNSS $1.48
  • Resistance Level
  • ANVS $2.97
  • GNSS $1.85
  • Average True Range (ATR)
  • ANVS 0.26
  • GNSS 0.10
  • MACD
  • ANVS 0.02
  • GNSS 0.05
  • Stochastic Oscillator
  • ANVS 65.58
  • GNSS 98.11

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

Share on Social Networks: